Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With ISN/RPS Class III or IV Lupus Nephritis (LUNAR)
This study is ongoing, but not recruiting participants.
Study NCT00282347 Information provided by Genentech
First Received: January 24, 2006 Last Updated: September 25, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lupus Nephritis
Additional conditions recognized in this trial
Nephritis
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Glomerulonephritis
Immune System Diseases
Kidney Diseases
Lupus Erythematosus, Systemic
Urologic Diseases
Interventions listed in this trial
corticosteroids
methylprednisolone
mycophenolate mofetil
placebo
rituximab
Additional drug interventions recognized in this trial
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Mycophenolic Acid
Prednisolone
Prednisolone acetate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Autonomic Agents
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Genentech
Back to top of Main Content
